Analysis of urinary caffeine metabolites by HPLC-DAD: the use of metabolic ratios to assess CYP1A2 enzyme activity

被引：30
|
作者：
Caubet, MS [1 ]
Elbast, W [1 ]
Dubuc, MC [1 ]
Brazier, JL [1 ]
机构：
[1] Hop St Justine, Ctr Rech, Fac Pharm, Chaire Med Grossesse & Allaitement, Montreal, PQ H3C 3J7, Canada
来源：
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 2002年 / 27卷 / 1-2期
关键词：
caffeine; caffeine metabolites ratios; phenotyping; CYP1A2;
D O I：
10.1016/S0731-7085(01)00546-5
中图分类号：
O65 [分析化学];
学科分类号：
070302 ; 081704 ;
摘要：
An improved extraction procedure and a new RP-HPLC method were developed for selective and rapid analysis of caffeine and 14 of its metabolites in urine. Analytes were isolated by solid-phase extraction and separated on an Eclipse XDB-C18 column. Recoveries ranged between 83 and 99%. Precision, linearity and accuracy of the chromatographic method were found to be within required limits. Using this procedure, caffeine metabolic ratios were determined in 20 subjects with characteristic CYP1A2 activities, relatively to smoking habit and contraceptives intake. The method might be useful to point out induction and inhibition of CYP1A2 activity. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码：261 / 270
页数：10
相关论文
共 35 条
  • [1] CAFFEINE AS A METABOLIC PROBE - A COMPARISON OF THE METABOLIC RATIOS USED TO ASSESS CYP1A2 ACTIVITY
    NOTARIANNI, LJ
    OLIVER, SE
    DOBROCKY, P
    BENNETT, PN
    SILVERMAN, BW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (01) : 65 - 69
  • [2] Determination of Caffeine and its Metabolites in Saliva and Urine as a Measure of CYP1A2 Metabolic Activity
    Turjap, Miroslav
    Zendulka, Ondrej
    Glatz, Zdenek
    Brejcha, Stanislav
    Madr, Ales
    Jurica, Jan
    CURRENT PHARMACEUTICAL ANALYSIS, 2016, 12 (04) : 325 - 332
  • [3] A POPULATION AND FAMILY STUDY OF CYP1A2 USING CAFFEINE URINARY METABOLITES
    CATTEAU, A
    BECHTEL, YC
    POISSON, N
    BECHTEL, PR
    BONAITIPELLIE, C
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 47 (05) : 423 - 430
  • [4] Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake
    Urry, Emily
    Jetter, Alexander
    Landolt, Hans-Peter
    NUTRITION & METABOLISM, 2016, 13 : 1 - 9
  • [5] Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake
    Emily Urry
    Alexander Jetter
    Hans-Peter Landolt
    Nutrition & Metabolism, 13
  • [6] HPLC ASSAY OF CAFFEINE AND PARAXANTHINE FOR CYP1A2 PHENOTYPE ASSESSMENT
    Rehman, S.
    Razzaq, A.
    Kamal, S.
    Bibi, I.
    Kiran, S.
    Nouren, S.
    Ayub, C. M.
    Hamid, M.
    OXIDATION COMMUNICATIONS, 2016, 39 (03): : 2344 - 2353
  • [7] Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe
    Perera, Vidya
    Gross, Annette S.
    McLachlan, Andrew J.
    CURRENT DRUG METABOLISM, 2012, 13 (05) : 667 - 678
  • [8] In vivo evaluation of CYP1A2 CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios
    Begas, E.
    Kouvaras, E.
    Tsakalof, A.
    Papakosta, S.
    Asprodini, E. K.
    BIOMEDICAL CHROMATOGRAPHY, 2007, 21 (02) : 190 - 200
  • [9] Caffeine Metabolic Ratios for the In Vivo Evaluation of CYP1A2, N-acetyltransferase 2, Xanthine Oxidase and CYP2A6 Enzymatic Activities
    Hakooz, Nancy M. Kh.
    CURRENT DRUG METABOLISM, 2009, 10 (04) : 329 - 338
  • [10] CLOZAPINE DISPOSITION COVARIES WITH CYP1A2 ACTIVITY DETERMINED BY A CAFFEINE TEST
    BERTILSSON, L
    CARRILLO, JA
    DAHL, ML
    LLERENA, A
    ALM, C
    BONDESSON, U
    LINDSTROM, L
    DELARUBIA, IR
    RAMOS, S
    BENITEZ, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (05) : 471 - 473
1234